Quick Answer
ENDRA Life Sciences Inc. reported Long Term Debt of $0.00 for the year ending 2024.
- This data is from ENDRA Life Sciences Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $510.1 thousand | Q2 2022: $472.7 thousand | Q3 2022: $434.3 thousand | Q1 2023: $324.1 thousand | Q2 2023: $281.2 thousand | Q1 2024: $0.00.
- Over the full 4 years of available data (2021 to 2024), ENDRA Life Sciences Inc.'s Long Term Debt has declined by 100.0%.
- Historical annual values: Fiscal year 2024: $0.00 | Fiscal year 2023: $0.00 | Fiscal year 2022: $0.00 | Fiscal year 2021: $546.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: